Manufacturing sites
Understand every manufacturing site worldwide — what it makes, who relies on it, and how it performs. QYOBO tracks compliance, news, and supply chains in real time, so you can make confident investment or sourcing decisions.
Explore every manufacturing site and how it performs. Here’s how QYOBO works.
QYOBO gives you full visibility into global pharmaceutical manufacturing — down to the individual site. Identify what each facility produces, its technologies and capabilities, and who owns it. Track compliance, news, and disruptions in real time, and understand which companies and markets rely on it. Whether you’re evaluating partners, scouting investments, or assessing supply resilience, QYOBO ensures you always have the complete picture.
Get complete visibility into any manufacturing site worldwide. See exactly what each site produces, where it is located, and whether it’s exposed to risks such as imminent natural disasters. Review its compliance history and certifications before you invest or partner. Instantly identify other sites producing the same or similar products and analyze manufacturing capabilities across key regions to guide reshoring and market-access strategies.
Search for manufacturing sites by the technologies, dosage forms, or production capabilities you need. Filter for capabilities such as sterile production, specific dosage forms like films, patches, or highly potent APIs. Whether you’re looking for facilities with EU GMP and ANVISA approvals or those producing monoclonal antibodies or beta-lactam antibiotics, QYOBO makes it effortless to identify the right sites for sourcing, investment, or competitive analysis.
Identify facilities available for acquisition. QYOBO maps corporate structures across subsidiaries, providing a clear, consolidated view of all assets within each group. Instantly see whether a company is publicly or privately owned, when an asset was acquired by private equity, and where it sits in the investment cycle — giving you the transparency to spot opportunities before anyone else.
Be the first to know about every relevant event affecting manufacturing worldwide. QYOBO tracks M&A deals, new approvals, investments, and disruptive events such as GMP non-compliance, accidents, natural disasters, recalls, and drug shortages — mapping each directly to the affected site, its products, and highlights affected supply chains. Understand the real impact instantly and act before anyone else.
Understand each site’s true role in the global pharmaceutical market. QYOBO shows where the drugs or APIs produced at a site ultimately end up, and which companies and markets rely on its output. Analyze whether the site is essential or easily replaceable within the global supply network, identify if buyers are multi-sourced or dependent on a single facility, and compare competitors operating similar sites.
Benefits
While Others Drown in Data, You’re Already Making the Right Moves.
Gain the most complete view of pharmaceutical manufacturing worldwide. QYOBO aggregates and analyzes data from over 300 sources to reveal exactly what each site produces, who owns it, and how its performance compares to competitors. With the richest dataset in the industry, you can assess every facility confidently, uncover hidden risks, and reduce uncertainty in sourcing or investment decisions.
Evaluate manufacturing partners or acquisition targets with speed and precision. QYOBO connects ownership, technologies, compliance, latest news and supply chain data into a single, intelligent view — helping you assess a site’s potential instantly. Make sourcing and investment decisions backed by verified facts, not assumptions.
See how every manufacturing site fits into the global pharmaceutical network. QYOBO shows which companies and markets rely on a facility and reveals viable alternatives to strengthen your sourcing or investment strategy. Whether you’re navigating reshoring, market access, or geopolitical risk, you gain the clarity to act decisively.
Success Story
QYOBO transforms how Accord Healthcare manages API procurement and planning.
“It takes five minutes to build a clear picture of the supply chain. That’s the benefit, we go from working one opportunity a week to ten. It sharpens our competitiveness and supports everything from risk planning to sustainability.”
Tony Watson
Director of Procurement, Accord Healthcare
More capabilities
One Platform. From Insight to Action.
See how QYOBO transforms pharma decision-making with AI-driven insights.
Questions?
Answers to your questions on how QYOBO’s Intelligence on Manufacturing Sites drives better pharma decisions.
QYOBO connects data on product, manufacturing technologies, compliance, site ownership and more in one single view, allowing you to evaluate manufacturing partners or acquisition targets instantly. Instead of manually researching hundreds of sources, you can assess each site’s track record and capabilities in seconds — making faster, better-informed decisions with far less assumptions and risk.
Yes. QYOBO maps each manufacturing site within the global supply network, showing which companies and markets rely on its products. You can compare each site to its peers to understand how essential it is, trace the downstream impact of potential disruptions, and identify where dependencies or opportunities exist.
QYOBO tracks corporate ownership, private equity involvement, and investment cycles across all manufacturing sites. You can instantly see when a facility was acquired, who owns it, and which products it makes — helping you spot assets likely to come to market that are aligned with your investment strategy.
Absolutely. QYOBO allows you to filter by specific technologies or dosage forms such as sterile production, transdermal patches, or highly potent APIs. You can even refine results by regional approvals like EU GMP or ANVISA to find facilities that precisely match your sourcing or investment criteria.
QYOBO provides a clear view of where critical products are made and how dependent each market or region is on foreign manufacturing. By mapping production capabilities across countries and comparing them to domestic alternatives, you can identify reshoring opportunities, evaluate supply gaps, and quantify how emerging local supply chains may impact your existing business.
